Works matching IS 17427835 AND DT 2022 AND VI 131 AND IP 2
Results: 7
Targeting the DNA repair enzymes MTH1 and OGG1 as a novel approach to treat inflammatory diseases.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 131, n. 2, p. 95, doi. 10.1111/bcpt.13765
- Publication type:
- Article
Comparison of ciprofol (HSK3486) versus propofol for the induction of deep sedation during gastroscopy and colonoscopy procedures: A multi‐centre, non‐inferiority, randomized, controlled phase 3 clinical trial.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 131, n. 2, p. 138, doi. 10.1111/bcpt.13761
- By:
- Publication type:
- Article
Lithium and the risk of chronic kidney disease: A population‐based case–control study.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 131, n. 2, p. 129, doi. 10.1111/bcpt.13758
- By:
- Publication type:
- Article
Medicines, environment and clinical pharmacology.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 131, n. 2, p. 149, doi. 10.1111/bcpt.13757
- By:
- Publication type:
- Article
First‐in‐human study with ACT‐1014‐6470, a novel oral complement factor 5a receptor 1 (C5aR1) antagonist, supported by pharmacokinetic predictions from animals to patients.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 131, n. 2, p. 114, doi. 10.1111/bcpt.13756
- By:
- Publication type:
- Article
Delineation of the GPR15 receptor‐mediated Gα protein signalling profile in recombinant mammalian cells.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 131, n. 2, p. 104, doi. 10.1111/bcpt.13738
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 131, n. 2, p. 93, doi. 10.1111/bcpt.13608
- Publication type:
- Article